Establishment and validation of a novel droplet digital PCR assay for ultrasensitive detection and dynamic monitoring of EGFR mutations in peripheral blood samples of non-small-cell lung cancer patients

Tang, Chuanhao; Zhu, Lingxiang; Zhang, Lijuan; Tan, Chianru; Peng, Zhiyong; Liu, Baoxia; Liu, Wenjing; Hu, Haixu; Bai, Yu; Wang, Bo; Lin, Li; Liang, Jun; Li, Xiaoyan; Guo, Yong; Liu, Yi

doi:10.1016/j.cca.2020.07.003

Title: Establishment and validation of a novel droplet digital PCR assay for ultrasensitive detection and dynamic monitoring of EGFR mutations in peripheral blood samples of non-small-cell lung cancer patients

Journal Article · Sun Nov 01 00:00:00 EDT 2020 · Clinica Chimica Acta

DOI:https://doi.org/10.1016/j.cca.2020.07.003· OSTI ID:1809381

Tang, Chuanhao; Zhu, Lingxiang; Zhang, Lijuan; Tan, Chianru; Peng, Zhiyong; Liu, Baoxia; Liu, Wenjing; Hu, Haixu; Bai, Yu; Wang, Bo; Lin, Li; Liang, Jun; Li, Xiaoyan; Guo, Yong; Liu, Yi

View Accepted Manuscript (Publisher)

Cite

Export

Save

Sponsoring Organization:: USDOE Office of Electricity (OE), Advanced Grid Research & Development. Power Systems Engineering Research

Grant/Contract Number:: 2019YFC1315703

OSTI ID:: 1809381

Journal Information:: Clinica Chimica Acta, Journal Name: Clinica Chimica Acta Vol. 510 Journal Issue: C; ISSN 0009-8981

Publisher:: ElsevierCopyright Statement

Country of Publication:: Netherlands

Language:: English

References (33)

Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer Schiller, Joan H.; Harrington, David; Belani, Chandra P. New England Journal of Medicine, Vol. 346, Issue 2 https://doi.org/10.1056/NEJMoa011954	journal	January 2002
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study Zhou, Caicun; Wu, Yi-Long; Chen, Gongyan The Lancet Oncology, Vol. 12, Issue 8 https://doi.org/10.1016/S1470-2045(11)70184-X	journal	August 2011
A comparison of ARMS and direct sequencing for EGFR mutation analysis and Tyrosine Kinase Inhibitors treatment prediction in body fluid samples of Non-Small-Cell Lung Cancer patients Liu, Yi; Liu, Bing; Li, Xiao-Yan Journal of Experimental & Clinical Cancer Research, Vol. 30, Issue 1 https://doi.org/10.1186/1756-9966-30-111	journal	December 2011
Highly Sensitive Droplet Digital PCR Method for Detection of EGFR-Activating Mutations in Plasma Cell–Free DNA from Patients with Advanced Non–Small Cell Lung Cancer Zhu, Guanshan; Ye, Xin; Dong, Zhengwei The Journal of Molecular Diagnostics, Vol. 17, Issue 3 https://doi.org/10.1016/j.jmoldx.2015.01.004	journal	May 2015
Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses Sundaresan, Tilak K.; Sequist, Lecia V.; Heymach, John V. Clinical Cancer Research, Vol. 22, Issue 5 https://doi.org/10.1158/1078-0432.CCR-15-1031	journal	October 2015
Epidermal growth factor receptor mutations in lung cancer Sharma, Sreenath V.; Bell, Daphne W.; Settleman, Jeffrey Nature Reviews Cancer, Vol. 7, Issue 3 https://doi.org/10.1038/nrc2088	journal	March 2007
Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer Wu, Shang-Gin; Shih, Jin-Yuan Molecular Cancer, Vol. 17, Issue 1 https://doi.org/10.1186/s12943-018-0777-1	journal	February 2018
Role of circulating-tumor DNA analysis in non-small cell lung cancer Jiang, Tao; Ren, Shengxiang; Zhou, Caicun Lung Cancer, Vol. 90, Issue 2 https://doi.org/10.1016/j.lungcan.2015.09.013	journal	November 2015
Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non–Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR Watanabe, Masaru; Kawaguchi, Tomoya; Isa, Shun-ichi Clinical Cancer Research, Vol. 21, Issue 15 https://doi.org/10.1158/1078-0432.CCR-14-2151	journal	April 2015
Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR -Mutant Lung Cancers Yu, Helena A.; Arcila, Maria E.; Rekhtman, Natasha Clinical Cancer Research, Vol. 19, Issue 8 https://doi.org/10.1158/1078-0432.CCR-12-2246	journal	March 2013
Total DNA input is a crucial determinant of the sensitivity of plasma cell-free DNA EGFR mutation detection using droplet digital PCR Zhang, Yu; Xu, Yan; Zhong, Wei Oncotarget, Vol. 8, Issue 4 https://doi.org/10.18632/oncotarget.14390	journal	December 2016
Epidermal growth factor receptor mutation analysis in previously unanalyzed histology samples and cytology samples from the phase III Iressa Pan-ASia Study (IPASS) Yang, James Chih-Hsin; Wu, Yi-Long; Chan, Valorie Lung Cancer, Vol. 83, Issue 2 https://doi.org/10.1016/j.lungcan.2013.11.021	journal	February 2014
Noninvasive Detection of Response and Resistance in EGFR -Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA Oxnard, Geoffrey R.; Paweletz, Cloud P.; Kuang, Yanan Clinical Cancer Research, Vol. 20, Issue 6 https://doi.org/10.1158/1078-0432.CCR-13-2482	journal	January 2014
Dynamics of EGFR mutations in plasma recapitulates the clinical response to EGFR-TKIs in NSCLC patients Xiong, Liwen; Cui, Shaohua; Ding, Jingyan Oncotarget, Vol. 8, Issue 38 https://doi.org/10.18632/oncotarget.19139	journal	July 2017
Cancer statistics, 2020 Siegel, Rebecca L.; Miller, Kimberly D.; Jemal, Ahmedin CA: A Cancer Journal for Clinicians, Vol. 70, Issue 1 https://doi.org/10.3322/caac.21590	journal	January 2020
Droplet digital PCR improved the EGFR mutation diagnosis with pleural fluid samples in non-small-cell lung cancer patients Li, Xiaoyan; Liu, Yi; Shi, Weiwei Clinica Chimica Acta, Vol. 471 https://doi.org/10.1016/j.cca.2017.06.007	journal	August 2017
Multiplex Ultrasensitive Genotyping of Patients with Non-Small Cell Lung Cancer for Epidermal Growth Factor Receptor (EGFR) Mutations by Means of Picodroplet Digital PCR Watanabe, Masaru; Kawaguchi, Tomoya; Isa, Shun-ichi EBioMedicine, Vol. 21 https://doi.org/10.1016/j.ebiom.2017.06.003	journal	July 2017
Predictive factors for EGFR -tyrosine kinase inhibitor retreatment in patients with EGFR -mutated non-small-cell lung cancer – A multicenter retrospective SEQUENCE study Chang, Gee-Chen; Tseng, Chien-Hua; Hsu, Kuo-Hsuan Lung Cancer, Vol. 104 https://doi.org/10.1016/j.lungcan.2016.12.002	journal	February 2017
Determining lower limits of detection of digital PCR assays for cancer-related gene mutations Milbury, Coren A.; Zhong, Qun; Lin, Jesse Biomolecular Detection and Quantification, Vol. 1, Issue 1 https://doi.org/10.1016/j.bdq.2014.08.001	journal	September 2014
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials Yang, James Chih-Hsin; Wu, Yi-Long; Schuler, Martin The Lancet Oncology, Vol. 16, Issue 2 https://doi.org/10.1016/S1470-2045(14)71173-8	journal	February 2015
Liquid biopsies come of age: towards implementation of circulating tumour DNA Wan, Jonathan C. M.; Massie, Charles; Garcia-Corbacho, Javier Nature Reviews Cancer, Vol. 17, Issue 4 https://doi.org/10.1038/nrc.2017.7	journal	February 2017
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma Mok, Tony S.; Wu, Yi-Long; Thongprasert, Sumitra New England Journal of Medicine, Vol. 361, Issue 10 https://doi.org/10.1056/NEJMoa0810699	journal	September 2009
Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer Sacher, Adrian G.; Paweletz, Cloud; Dahlberg, Suzanne E. JAMA Oncology, Vol. 2, Issue 8 https://doi.org/10.1001/jamaoncol.2016.0173	journal	August 2016
A “quasi” confocal droplet reader based on laser-induced fluorescence (LIF) cytometry for highly-sensitive and contamination-free detection Zhu, Xiurui; Liu, Baoxia; Su, Shisheng Talanta, Vol. 206 https://doi.org/10.1016/j.talanta.2019.120200	journal	January 2020
Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial Shi, Yuankai; Zhang, Li; Liu, Xiaoqing The Lancet Oncology, Vol. 14, Issue 10 https://doi.org/10.1016/S1470-2045(13)70355-3	journal	September 2013
The causes and consequences of genetic heterogeneity in cancer evolution Burrell, Rebecca A.; McGranahan, Nicholas; Bartek, Jiri Nature, Vol. 501, Issue 7467 https://doi.org/10.1038/nature12625	journal	September 2013
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer Mok, Tony S.; Wu, Yi-Long; Ahn, Myung-Ju New England Journal of Medicine, Vol. 376, Issue 7 https://doi.org/10.1056/NEJMoa1612674	journal	February 2017
Different treatment orders achieved similar clinical results: a retrospective study for retreatment of epidermal growth factor receptor tyrosine kinase inhibitors in 120 patients with non-small-cell lung cancer Tang, Chuanhao; Gao, Hongjun; Li, Xiaoyan Journal of Cancer Research and Clinical Oncology, Vol. 140, Issue 3 https://doi.org/10.1007/s00432-014-1582-x	journal	January 2014
Advances in digital polymerase chain reaction (dPCR) and its emerging biomedical applications Cao, Lei; Cui, Xingye; Hu, Jie Biosensors and Bioelectronics, Vol. 90 https://doi.org/10.1016/j.bios.2016.09.082	journal	April 2017
Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial Wang, Zhijie; Cheng, Ying; An, Tongtong The Lancet Respiratory Medicine, Vol. 6, Issue 9 https://doi.org/10.1016/S2213-2600(18)30264-9	journal	September 2018
Ultra-sensitive EGFR ^T790M Detection as an Independent Prognostic Marker for Lung Cancer Patients Harboring EGFR ^del19 Mutations and Treated with First-generation TKIs Vendrell, Julie A.; Mazieres, Julien; Senal, Romain Clinical Cancer Research, Vol. 25, Issue 14 https://doi.org/10.1158/1078-0432.CCR-18-2683	journal	April 2019
Developing Ultrasensitive Library-Aliquot-Based Droplet Digital PCR for Detecting T790M in Plasma-Circulating Tumor DNA of Non-small-Cell-Lung-Cancer Patients Yang, Ke; Li, Jun; Zhao, Jiuzhou Analytical Chemistry, Vol. 90, Issue 19 https://doi.org/10.1021/acs.analchem.8b01776	journal	August 2018
Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update Kalemkerian, Gregory P.; Narula, Navneet; Kennedy, Erin B. Journal of Clinical Oncology, Vol. 36, Issue 9 https://doi.org/10.1200/JCO.2017.76.7293	journal	March 2018

Similar Records

Potential influence of interleukin-6 on the therapeutic effect of gefitinib in patients with advanced non-small cell lung cancer harbouring EGFR mutations

Journal Article · Mon Jan 15 00:00:00 EST 2018 · Biochemical and Biophysical Research Communications · OSTI ID:1809381

Tamura, Tomoki; Kato, Yuka; Ohashi, Kadoaki; +3 more

Development and Validation of a Prognostic Model Using Blood Biomarker Information for Prediction of Survival of Non-Small-Cell Lung Cancer Patients Treated With Combined Chemotherapy and Radiation or Radiotherapy Alone (NCT00181519, NCT00573040, and NCT00572325)

Journal Article · Sat Oct 01 00:00:00 EDT 2011 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:1809381

Dehing-Oberije, Cary; Aerts, Hugo; Shipeng, Yu; +6 more

Early emergence of de novo EGFR T790M gatekeeper mutations during erlotinib treatment in PC9 non-small cell lung cancer cells

Journal Article · Sat Sep 15 00:00:00 EDT 2018 · Biochemical and Biophysical Research Communications · OSTI ID:1809381

Kim, Sujin; Park, Angela KJ.; Cho, Jeonghee

Title: Establishment and validation of a novel droplet digital PCR assay for ultrasensitive detection and dynamic monitoring of EGFR mutations in peripheral blood samples of non-small-cell lung cancer patients

Citation Formats

References (33)

Similar Records

Related Subjects